1 Guidance

1 Guidance

1.1 Dexamethasone intravitreal implant is recommended as an option for the treatment of macular oedema following central retinal vein occlusion.

1.2 Dexamethasone intravitreal implant is recommended as an option for the treatment of macular oedema following branch retinal vein occlusion when:

  • treatment with laser photocoagulation has not been beneficial, or

  • treatment with laser photocoagulation is not considered suitable because of the extent of macular haemorrhage.

1.3 People currently receiving dexamethasone intravitreal implant for the treatment of macular oedema secondary to branch retinal vein occlusion who do not meet the criteria specified in 1.2 above should have the option to continue treatment until they and their clinicians consider it appropriate to stop.

  • National Institute for Health and Care Excellence (NICE)